AAPL   322.16 (+1.03%)
MSFT   185.22 (+0.93%)
FB   240.18 (+2.24%)
GOOGL   1,440.68 (+1.94%)
AMZN   2,454.38 (+0.64%)
NVDA   362.80 (+0.38%)
CGC   20.64 (+5.47%)
BABA   205.95 (+3.13%)
TSLA   827.26 (+1.27%)
AMD   55.88 (+0.81%)
T   30.71 (+2.78%)
ACB   15.58 (-2.68%)
F   5.92 (+4.60%)
GILD   72.97 (-0.50%)
NFLX   423.47 (-1.36%)
BAC   23.87 (+5.34%)
BA   144.21 (+4.86%)
AAPL   322.16 (+1.03%)
MSFT   185.22 (+0.93%)
FB   240.18 (+2.24%)
GOOGL   1,440.68 (+1.94%)
AMZN   2,454.38 (+0.64%)
NVDA   362.80 (+0.38%)
CGC   20.64 (+5.47%)
BABA   205.95 (+3.13%)
TSLA   827.26 (+1.27%)
AMD   55.88 (+0.81%)
T   30.71 (+2.78%)
ACB   15.58 (-2.68%)
F   5.92 (+4.60%)
GILD   72.97 (-0.50%)
NFLX   423.47 (-1.36%)
BAC   23.87 (+5.34%)
BA   144.21 (+4.86%)
AAPL   322.16 (+1.03%)
MSFT   185.22 (+0.93%)
FB   240.18 (+2.24%)
GOOGL   1,440.68 (+1.94%)
AMZN   2,454.38 (+0.64%)
NVDA   362.80 (+0.38%)
CGC   20.64 (+5.47%)
BABA   205.95 (+3.13%)
TSLA   827.26 (+1.27%)
AMD   55.88 (+0.81%)
T   30.71 (+2.78%)
ACB   15.58 (-2.68%)
F   5.92 (+4.60%)
GILD   72.97 (-0.50%)
NFLX   423.47 (-1.36%)
BAC   23.87 (+5.34%)
BA   144.21 (+4.86%)
AAPL   322.16 (+1.03%)
MSFT   185.22 (+0.93%)
FB   240.18 (+2.24%)
GOOGL   1,440.68 (+1.94%)
AMZN   2,454.38 (+0.64%)
NVDA   362.80 (+0.38%)
CGC   20.64 (+5.47%)
BABA   205.95 (+3.13%)
TSLA   827.26 (+1.27%)
AMD   55.88 (+0.81%)
T   30.71 (+2.78%)
ACB   15.58 (-2.68%)
F   5.92 (+4.60%)
GILD   72.97 (-0.50%)
NFLX   423.47 (-1.36%)
BAC   23.87 (+5.34%)
BA   144.21 (+4.86%)
Log in

NYSEARCA:PPHVanEck Vectors Pharmaceutical ETF Stock Price, Forecast & News

$61.41
-0.27 (-0.44 %)
(As of 05/26/2020 08:46 AM ET)
Add
Today's Range
$61.13
Now: $61.41
$61.64
50-Day Range
$52.62
MA: $59.32
$61.97
52-Week Range
$46.90
Now: $61.41
$68.02
Volume13,500 shs
Average Volume79,538 shs
Market Capitalization$229.55 million
P/E RatioN/A
Dividend Yield1.76%
BetaN/A

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.83 out of 5 stars


Basic Details

Issuer Van Eck
Fund NameVanEck Vectors Pharmaceutical ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:PPH
Inception Date12/20/2011
Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkMarket Vectors US Listed Pharmaceutical 25 Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionGlobal

Fund Statistics

Assets Under Management$229.90 million
Average Daily Volume$38,900.60
Discount/Premium0.01%

ETF Expenses

Management Fee0.35%
Other Expenses0.05%
Total Expenses0.40%
Fee Waiver-0.05%
Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorVan Eck Associates Corporation
AdvisorVan Eck Associates Corporation
CustodianState Street Bank and Trust Company
DistributorVan Eck Securities Corporation
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market Maker

Receive PPH News and Ratings via Email

Sign-up to receive the latest news and ratings for PPH and its competitors with MarketBeat's FREE daily newsletter.

Geographic Exposure of VanEck Vectors Pharmaceutical ETF (NYSEARCA:PPH)
Currency Exposure of VanEck Vectors Pharmaceutical ETF (NYSEARCA:PPH)
Sector Exposure of VanEck Vectors Pharmaceutical ETF (NYSEARCA:PPH)
Industry Exposure of VanEck Vectors Pharmaceutical ETF (NYSEARCA:PPH)

VanEck Vectors Pharmaceutical ETF (NYSEARCA:PPH) Frequently Asked Questions

How has VanEck Vectors Pharmaceutical ETF's stock been impacted by COVID-19 (Coronavirus)?

VanEck Vectors Pharmaceutical ETF's stock was trading at $56.63 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, PPH stock has increased by 8.4% and is now trading at $61.41. View which stocks have been most impacted by Coronavirus.

How often does VanEck Vectors Pharmaceutical ETF pay dividends? What is the dividend yield for VanEck Vectors Pharmaceutical ETF?

VanEck Vectors Pharmaceutical ETF declared a quarterly dividend on Monday, December 30th. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.1729 per share on Monday, January 6th. This represents a $0.69 annualized dividend and a yield of 1.13%. The ex-dividend date of this dividend is Monday, December 30th. View VanEck Vectors Pharmaceutical ETF's dividend history.

Has VanEck Vectors Pharmaceutical ETF been receiving favorable news coverage?

Headlines about PPH stock have trended negative on Tuesday, according to InfoTrie. The research firm identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. VanEck Vectors Pharmaceutical ETF earned a coverage optimism score of -2.1 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutVanEck Vectors Pharmaceutical ETF.

What other stocks do shareholders of VanEck Vectors Pharmaceutical ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Vectors Pharmaceutical ETF investors own include Comcast (CMCSA), Mcdonald's (MCD), Pfizer (PFE), Procter & Gamble (PG), AT&T (T), Bank of America (BAC), Citigroup (C), Walt Disney (DIS), Gilead Sciences (GILD) and Corning (GLW).

What is VanEck Vectors Pharmaceutical ETF's stock symbol?

VanEck Vectors Pharmaceutical ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "PPH."

Who are VanEck Vectors Pharmaceutical ETF's major shareholders?

VanEck Vectors Pharmaceutical ETF's stock is owned by many different institutional and retail investors. Top institutional shareholders include BNP Paribas Arbitrage SA (2.62%), Morgan Stanley (0.72%), Wintrust Investments LLC (0.30%), UBS Group AG (0.28%), Oppenheimer & Co. Inc. (0.27%) and Dfpg Investments LLC (0.30%).

Which institutional investors are selling VanEck Vectors Pharmaceutical ETF stock?

PPH stock was sold by a variety of institutional investors in the last quarter, including BNP Paribas Arbitrage SA, Morgan Stanley, Wells Fargo & Company MN, UBS Group AG, KCM Investment Advisors LLC, Oppenheimer & Co. Inc., Cutler Group LP, and North Star Investment Management Corp..

Which institutional investors are buying VanEck Vectors Pharmaceutical ETF stock?

PPH stock was purchased by a variety of institutional investors in the last quarter, including Dfpg Investments LLC, Advisor Group Holdings Inc., Meitav Dash Investments Ltd., Wintrust Investments LLC, and Raymond James & Associates.

How do I buy shares of VanEck Vectors Pharmaceutical ETF?

Shares of PPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is VanEck Vectors Pharmaceutical ETF's stock price today?

One share of PPH stock can currently be purchased for approximately $61.41.

How big of a company is VanEck Vectors Pharmaceutical ETF?

VanEck Vectors Pharmaceutical ETF has a market capitalization of $229.55 million.

What is VanEck Vectors Pharmaceutical ETF's official website?

The official website for VanEck Vectors Pharmaceutical ETF is www.vaneck.com.

This page was last updated on 5/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.